RSS Feeds | GenomeWeb

In Nature this week: methylation analysis methods compared, and more.

A trial by Tesaro indicates that its PARP inhibitor can limit ovarian cancer growth in patients with and without BRCA mutations.

A National Academies of Sciences, Engineering, and Medicine report recommends that the attempt to revise the Common Rule start over again, NPR reports.

Biotech Orig3N has a deal with the San Francisco 49ers to collect blood samples from fans to build its repository, NinersNation reports.